Forskning
Amit er forsker ved Universitetet i Bergen og har lisens som lege i Norge. Han har tidligere fullført en bachelorgrad i medisin og kirurgi (DMC&H, India), samt tre diplomer: i allmennmedisin (Royal College of General Practitioners, Storbritannia), idrettsmedisin med særskilt fokus på fotball (FIFA), og avhengighetsmedisin (University of British Columbia, Canada). Videre har han oppnådd en mastergrad i internasjonal helse (Universitetet i Oslo, Norge), et graduate‑sertifikat i translational neurotechnology I (NCIL, Canada), et undervisningssertifikat fra University of Melbourne (Australia), samt en doktorgrad (PhD) i medisin ved Universitetet i Bergen.
Hans forskningsinteresser og erfaring spenner over samfunnsmedisin, reisemedisin og infeksjonsmedisin, immunologi, idrettsmedisin, nevroplastisitet og aterosklerose, samt onkologiske problemstillinger relatert til hudkreft, brystkreft, livmorhalskreft, tykktarmskreft og prostatakreft.
Publikasjoner
Vitenskapelig artikkel
- Amit Bansal (2023). From rejection to the Nobel Prize: Karikó and Weissman’s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology. (ekstern lenke)
- Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (ekstern lenke)
- Håkon Amdam; Anders Madsen; Fan Zhou et al. (2021). Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). (ekstern lenke)
- Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (ekstern lenke)
- Kanika Kuwelker; Fan Zhou; Bjørn Blomberg et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (ekstern lenke)
- Lena Hansen; Karl Albert Brokstad; Amit Bansal et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (ekstern lenke)
- Amit Bansal; Ida Sofie Karlsen Sletten; Le, Tung Thanh et al. (2026). Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats | Systematic Reviews. (ekstern lenke)
- Amit Bansal (2025). Economic burden of long COVID: macroeconomic, cost-of-illness and microeconomic impacts. (ekstern lenke)
- Nina Urke Ertesvåg; Julie Xiao; Fan Zhou et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (ekstern lenke)
- Mai Chi Trieu; Amit Bansal; Anders Madsen et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (ekstern lenke)
- Mai Chi Trieu; Amit Bansal; Marianne Sævik et al. (2025). Effects of repeated influenza vaccination and infection on durable seroprotection in healthcare workers. (ekstern lenke)
- Amit Bansal; Mai Chi Trieu; Emily M. Eriksson et al. (2025). SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis. (ekstern lenke)
Konferanseforedrag
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Low infection and seroconversion rates in frontline healthcare workers during the peak of the Coronavirus disease 2019 pandemic in Bergen, Norway. (ekstern lenke)
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). SARS-COV-2-Specific neutralising antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (ekstern lenke)
- Amit Bansal (2025). Seroepidemiology, biomarkers, and economic costs of long COVID. (ekstern lenke)
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Antibody responses to SARS-CoV-2 virus in Norwegian health-care workers: an observational prospective cohort study. (ekstern lenke)
- Ingeborg Yddal; Sarah Larteley Lartey Jalloh; Anders Madsen et al. (2025). Longevity and functionality of influenza vaccine responses in young children and pregnant women in rural Bangladesh. (ekstern lenke)
- Amit Bansal; Sam W.Z. Olechnowicz; Nicholas Kiernan-Walker et al. (2025). Plasma proteomic signatures in long COVID: Potential targets for next-generation vaccines. (ekstern lenke)
Doktorgradsavhandling
Konferanseposter
- Ingeborg Yddal; Sarah Larteley Lartey; Warda Haque et al. (2025). Vaccine Response after Quadrivalent Influenza Vaccination in Children <5 Years of Age in Rural Bangladesh. (ekstern lenke)
- Ingeborg Yddal; Khalequz Zaman; Warda Haque et al. (2023). Respiratory Virus Surveillance in Rural Bangladesh During an Influenza Vaccine Effectiveness Trial of Young Children and Pregnant Women. (ekstern lenke)
- Ingeborg Yddal; Sarah Lartey; Warda Haque et al. (2024). Immunogenicity after influenza vaccination in young children <5 years old in rural Bangladesh. (ekstern lenke)
- Amit Bansal; Tung Thanh Le; Stig Tollefsen et al. (2025). Systematic Review Protocol: Establishment and Analysis of Landscapes for Candidate Platforms and Vaccines Against Current and Emerging Viral Threats. (ekstern lenke)
- Ingeborg Yddal; Sarah Lartey; Amit Bansal et al. (2023). Immunogenicity after influenza-vaccine in young children and pregnant women in rural Bangladesh. (ekstern lenke)
- Ingeborg Yddal; Sarah Larteley Lartey; Amit Bansal et al. (2023). Influenza-specific antibody responses after Influenza vaccination in young children and pregnant women in rural Bangladesh. (ekstern lenke)
- Ingeborg Yddal; Sarah Larteley Lartey Jalloh; Warda Haque et al. (2025). Influenza Vaccine Responses in Young Children in Bangladesh. (ekstern lenke)
- Amalie Borlaug; Anders Madsen; Sarah Larteley Lartey et al. (2025). Measuring influenza vaccine immunogenicity in young children and pregnant women in Bangladesh. (ekstern lenke)